Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting

Archives of Internal Medicine

Volumn 163, Issue 7, 2003, Pages 797-802

  Malcolm, Christine ^a   Marrie, Thomas J ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b 2F130 W C Mackenzie Hlth Sci C ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFACLOR; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINCOSAMIDE; MACROLIDE; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN G; PENICILLIN V; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE;

ADOLESCENT; ADULT; AGE; AGED; AMBULATORY CARE; ANTIBIOTIC THERAPY; ARTICLE; CANADA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG INDICATION; EMERGENCY WARD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ALBERTA; AMBULATORY CARE; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CLARITHROMYCIN; COMMUNITY-ACQUIRED INFECTIONS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OFLOXACIN; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 0344522707     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.7.797     Document Type: Article

References (22)

1. Bates JH, Campbell GD, Barron AL, et al. Microbial etiology of acute pneumonia in hospitalized patients. Chest. 1992;101:1005-1012.
2. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multi-center study of 359 cases. Medicine (Baltimore). 1990;69:307-316.
3. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: a 5-year prospective study. Rev Infect Dis. 1989;11:586-599.
4. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process and outcomes in elderly patients with pneumonia. JAMA. 1997;278:2080-2084.
5. Doern GV, Brueggemann A, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother. 1996;40:1208-1213.
6. Thornsberry C, Ogilvie P, Kahn J, Mauriz Y, for the Laboratory Investigator Group. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. Diagn Microbiol Infect Dis. 1997;29:249-257.
7. Zhanel GG, Karlowsky JA, Palatnick L, et al. Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. Antimicrob Agents Chemother. 1999;43: 2504-2509.
8. Dubois RW, Brook RH. Preventable deaths: who, how often and why. Ann Intern Med. 1988;109:582-589.
9. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH, and the Canadian Community-Acquired Pneumonia Working Group. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis. 2000;31:383-421.
10. Bartlett JG, Dowell SF, Mandell LA, File Jr [sic] TM, Musher DM, Fine MJ. Infectious Diseases Society of America practice guidelines for community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis. 2000;31: 347-382.
11. 1996 Census of Canada. Toronto, Ontario: Statistics Canada; 1996.
12. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: Wiley; 1989.
13. Laurichesse H, Robin F, Gerbaud L, et al. Empirical therapy for nonhospitalized patients with community-acquired pneumonia. Eur Respir J. 1998;11:73-78.
14. Fantin B, Aubert JP, Unger P, Lecoeur H, Carbon C. Clinical evaluation of the management of community-acquired pneumonia by general practitioners in France. Chest. 2001;120:185-192.
15. Gotfried MH. Epidemiology of clinically diagnosed community-acquired pneumonia in the primary care setting: results from the 1999-2000 respiratory surveillance program. Am J Med. 2001;111:25S-29S.
16. Fine MJ, Stone RA, Singer DE, et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med. 1999; 159:970-980.
17. Gilbert K, Gleason PP, Singer DE, et al. Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia. Am J Med. 1998;104:17-27.
18. Gleason PP, Kapoor WN, Stone WN, et al. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia. JAMA. 1997;278:32-39.
19. Marras TK, Chan CK. Use of guidelines in treating community-acquired pneumonia. Chest. 1998;113;1689-1694.
20. Minogue MF, Coley CM, Fine MJ, Marrie TJ, Kapoor WN, Singer DE. Patients hospitalized after initial outpatient treatment for community-acquired pneumonia. Ann Emerg Med. 1998;31:376-380.
21. Young M, Marrie TJ. Interobserver variability in the interpretation of chest roentgenograms of patients with possible pneumonia. Arch Intern Med. 1994;154: 2729-2732.
22. Melbye H, Dale K. Interobserver variability in the radiographic diagnosis of adult outpatient pneumonia. Acta Radiol. 1992;33:79-81.